AKAN (Akanda) Debt-to-Equity : 0.08 (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Akanda Debt-to-Equity?

Akanda's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $0.37 Mil. Akanda's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $0.00 Mil. Akanda's Total Stockholders Equity for the quarter that ended in Jun. 2024 was $4.57 Mil. Akanda's debt to equity for the quarter that ended in Jun. 2024 was 0.08.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Akanda's Debt-to-Equity or its related term are showing as below:

AKAN' s Debt-to-Equity Range Over the Past 10 Years
Min: -4.35 Med: 0.08 Max: 0.24
Current: 0.08

During the past 5 years, the highest Debt-to-Equity Ratio of Akanda was 0.24. The lowest was -4.35. And the median was 0.08.

AKAN's Debt-to-Equity is ranked better than
74.39% of 820 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs AKAN: 0.08

Akanda Debt-to-Equity Historical Data

The historical data trend for Akanda's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akanda Debt-to-Equity Chart

Akanda Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

N/A

-1.81

-4.35

0.15

-1.04

Akanda Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Equity	Get a 7-Day Free Trial			0.11	0.15	0.24	-1.04	0.08

Competitive Comparison of Akanda's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Akanda's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akanda's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Akanda's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Akanda's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Akanda Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Akanda's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.502	+	2.497)	/	-3.829
	=	-1.04

Akanda's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.374	+	0)	/	4.57
	=	0.08

Akanda (NAS:AKAN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Akanda Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Akanda's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Akanda Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (NAS:AKAN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

Y230:Germany

Address

1A, 1B Learoyd Road, New Romney, GBR, TN28 8XU

Website

https://www.akandacorp.com

Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.